Secure .gov websites use HTTPS
Box 1
Container
Contains 30 Results:
Tabor, Herbert, Dec. 16, 1986
File — Box: 1, Folder: 25
Scope and Contents
Institution: NIH/NIDDK. Topics: Educational background; Harvard, Columbia, Yale as centers of American biochemistry; Baird Hastings, DeWitt Stetten; first job as PHS Commissioned Officer in 1943 on board Coast Guard cutters; beginnings of NIH research community with Heppel, Horecker, Kornberg; lunch time seminars process; research environment in academia; anti-Semitism and war years, impact at Harvard, Yale, Columbia, why so many top biochemists came to Columbia; Southern gentleman culture...
Dates:
Dec. 16, 1986
Vita, Giulio, Feb. 5, 1987
File — Box: 1, Folder: 26
Scope and Contents
Institution: Bristol-Myers. Topics: How most new drugs are discovered by industry and not by academia; how hard it is to go from a lab to mass production, huge risks involved; industry involved in basic research to understand the underlying mechanisms of diseases, Bristol Myers on verge of breakthroughs in cancer research and infectious disease, genetic engineering and microbiology, receptorology, cell biology; where does this leadership value-set come from; importance of academia for new...
Dates:
Feb. 5, 1987
Waldmann, Thomas, Dec. 4, 1986
File — Box: 1, Folder: 27
Scope and Contents
Institution: NIH/NCI. Topics: Family genealogy; first interests in becoming a scientist; interface between basic science and clinical medicine; getting his start in immunology, intestinal lymphangiectasia research; collaborative culture of NIH; human suppressor cells discovery and research; molecular biology of immunoglobulin and T-cell receptor genes and interleukin-2 receptor to understand cell malignancy/leukemia, method for defining clonality as diagnostic tool; interleukin-2 or T-Cell...
Dates:
Dec. 4, 1986
Welch, Arnold, Nov. 22, 1986
File — Box: 1, Folder: 28
Scope and Contents
Institution: Sharpe and Dohme; Western Reserve; Squibb. Topics: Educational background, family genealogy; getting started in pharmacology with Carl and Gerty Cori in St. Louis; leaving Western Reserve for oncology program at Sharpe and Dohme, impact on career going to industry vs. academia; politics of pharmacology and Cori's research; difficulties of protein research; status of drug companies and industry research in 1940s, Merck, Sharpe and Dohme, Lilly; starting a research division from...
Dates:
Nov. 22, 1986
Wiseman, Edward, Feb. 13, 1987
File — Box: 1, Folder: 29
Scope and Contents
Institution: Pfizer. Topics: importance of information sharing in science, even in industry; human dimension of drug creation, bringing non-steroidal anti-inflammation research to Pfizer with Joe Lombardino in 1962; major arthritis treatment regimens and drugs during 1960s, human element of understanding the systemic disease as new piece of corporate strategy to strategically develop other drugs and therapies, commercial viability of that approach; discovering oxicams, Feldene and its...
Dates:
Feb. 13, 1987
Young, John P., Jan. 30, 1987
File — Box: 1, Folder: 30
Scope and Contents
Institution: Smith, Kline, French. Topics: Rhone-Poulenc corporate culture/character; joined company in 1952 just before getting chlorpromazine license; discovering its antipsychotic characteristics; history of other companies being offered chlorpromazine; internal skepticism and difficulties of developing the drug and antipsychotics as a business area in general, commercial viability of antipsychotic marketplace in 1950s; story of its first experimental use, demonstrable effect led to...
Dates:
Jan. 30, 1987
Bloom, Barry and Michael Page, Feb. 13, 1987
File — Box: 1, Folder: 1
Scope and Contents
Institution: Pfizer. Topics: entering into the field of recombinant DNA research and molecular genetics; recombinant techniques used in oncology; oncogenes; research efforts; using small biotechnology companies as part of research strategy; tPA processing technique for generating protein treatments; strategic drug production directions; developing a competitive edge; in-house scientific culture; benefits of being a multi-national organization; understanding patient/physician and basic...
Dates:
Feb. 13, 1987
Carter, Stephen, Feb. 5, 1987
File — Box: 1, Folder: 2
Scope and Contents
Institution: NIH/NCI; Bristol-Myers. Topics: Clinical trials development; MOPP/POPP Hodgkin's disease treatments; leukemia; chemotherapy; Vincent DeVita; Gordon Zubrod; Howard Skipper; cell kill hypothesis; Tom Frei and Jay Freireich; NCI cancer screening program; Platinol; leadership figures; coming to Bristol-Myers; commercial industry research approach; entry into biotechnology; interferon failure; non-approved indicator drug use.
Dates:
Feb. 5, 1987
Cohen, Sheldon and Bernard Janicki, Dec. 17, 1986
File — Box: 1, Folder: 3
Scope and Contents
Institution: NIH/NIAID. Topics: immunology as a recent newcomer within NIH 1960s-1970s; historical connections between NYU and NIH, Shannon, Benacerraff and predecessors; coming to NIH after Jonestown Flood; training program evaluation; Maurice Landy; reasons for growth of immunology at NIH since 1972; four areas of interest: basic immunobiology, genetics and transplantation, allergic diseases/hypersensitivity responses, immunodeficiency and autoimmune diseases; senescence; shift from...
Dates:
Dec. 17, 1986
DeVita, Vincent, Dec. 16, 1986
File — Box: 1, Folder: 4
Scope and Contents
Institution: NIH/NCI. Topics: immunologists as musicians; coming to NIH, Dave Rall, pharmacology; Hodgkin's disease research; role in war on cancer; Yarborough Commission; Mary Lasker influence; developing research agendas, Friday seminars, oncogenes, molecular biology, supercomputers; an independent NCI; entrepreneurial corporate culture of NCI; personal success developing Hodgkin's disease therapy; human tumor cell kinetic studies ; MOMP chemotherapy program; Freireich's influence;...
Dates:
Dec. 16, 1986